Cargando…

Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)

Detalles Bibliográficos
Autor principal:	Jeon, Ja Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369210/ https://www.ncbi.nlm.nih.gov/pubmed/34352989 http://dx.doi.org/10.4093/dmj.2021.0129

Ejemplares similares

Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
por: Kim, Kyoung Jin, et al.
Publicado: (2021)

Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus (Diabetes Metab J 2021;45:109-14)
por: Noh, Junghyun
Publicado: (2021)

Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus (Diabetes Metab J 2021;45:109-14)
por: Park, Sung-Don, et al.
Publicado: (2021)

Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals (Diabetes Metab J 2021;45:27-42)
por: Fustes, Otto Jesus Hernandez
Publicado: (2021)

Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals (Diabetes Metab J 2021;45:27-42)
por: Jin, Heung Yong, et al.
Publicado: (2021)

Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction (Diabetes Metab J 2021;45:270-4)
por: Kim, Bo-Yeon
Publicado: (2021)

Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction (Diabetes Metab J 2021;45:270-4)
por: Lee, Chan-Hee
Publicado: (2021)

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54)
por: Yang, Ye Seul, et al.
Publicado: (2021)

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54)
por: Baek, Jong Ha, et al.
Publicado: (2021)

Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018 (Diabetes Metab J 2021;45:880-9)
por: Chae, Jiun, et al.
Publicado: (2022)

Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018 (Diabetes Metab J 2021;45:880-9)
por: Kim, Dae Jung
Publicado: (2022)

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
por: Schernthaner, Guntram
Publicado: (2021)

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
por: Rhee, Sang Youl
Publicado: (2021)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
por: Kim, Mi-kyung
Publicado: (2021)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
por: Han, Eugene, et al.
Publicado: (2021)

Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study
por: Kim, Kyoung Jin, et al.
Publicado: (2021)

Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89)
por: Jung, Inha, et al.
Publicado: (2021)

Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89)
por: Kim, Jin Hwa
Publicado: (2021)

Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9)
por: Moon, Seong-Su, et al.
Publicado: (2021)

Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015) (Diabetes Metab J 2021;45:115-9)
por: Csákvári, Tímea, et al.
Publicado: (2021)

Fetal Abdominal Obesity Detected At 24 to 28 Weeks of Gestation Persists Until Delivery Despite Management of Gestational Diabetes Mellitus (Diabetes Metab J 2021;45:547-57)
por: Kim, Kyung-Soo
Publicado: (2021)

Fetal Abdominal Obesity Detected at 24 to 28 Weeks of Gestation Persists until Delivery Despite Management of Gestational Diabetes Mellitus (Diabetes Metab J 2021;45:547-57)
por: Kim, Wonjin, et al.
Publicado: (2021)

Patterns of glycemic control using glycosylated hemoglobin in diabetics
por: Kahlon, Arunpreet Singh, et al.
Publicado: (2011)

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
por: Moon, Jun Sung, et al.
Publicado: (2022)

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
por: Oh, Tae Jung
Publicado: (2022)

Letter: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)
por: Kim, Kyung-Soo
Publicado: (2016)

Response: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)
por: Kang, Yang Ho
Publicado: (2016)

The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
por: Min, Rui, et al.
Publicado: (2023)

Evaluation of Glycemic Control in Type 2 Diabetes Mellitus using Cytomorphometry of Buccal Cells and Correlation with Glycosylated Hemoglobin
por: Karthik, K Raghavendhar, et al.
Publicado: (2015)

Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus
por: Rayis, Duria A., et al.
Publicado: (2020)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Lee, Joonyub, et al.
Publicado: (2021)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Lee, Joonyub, et al.
Publicado: (2021)

Correlations between glycosylated hemoglobin and glucose levels in Chinese older adults with newly diagnosed type 2 diabetes mellitus
por: YU, Yun, et al.
Publicado: (2022)

Correlation between glycosylated hemoglobin level of patients with diabetes and cardiovascular disease
por: Wei, Fengyun
Publicado: (2019)

SAT-LB027 Does Diabetes Education Influence Glycosylated Hemoglobin?
por: Bhargava, Pooja, et al.
Publicado: (2019)

Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients
por: Cabrales, Pedro, et al.
Publicado: (2008)

The Usefulness of the Glycosylated Hemoglobin Level for the Diagnosis of Gestational Diabetes Mellitus in the Korean Population
por: Ryu, Ah Jeong, et al.
Publicado: (2015)

The utility of fasting plasma glucose in predicting glycosylated hemoglobin in type 2 diabetes
por: Al-Lawati, Jawad Ahmed, et al.
Publicado: (2007)

Glycosylated Hemoglobin as an Independent Prognostic Marker in COVID-19 Patients With Diabetes Mellitus
por: Dalia, Gopakumar, et al.
Publicado: (2022)

Association of Glycosylated Hemoglobin Level and Cancer-Related Mortality in Patients without Diabetes
por: Yoo, Tae Kyung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g56e2nk2j93p56c0m4ufpbs040